The progression of invasiveness regarding the role of transforming growth factor β receptor type II in gastric cancer

European Journal of Surgical Oncology

Volumn 26, Issue 4, 2000, Pages 377-380

  Tateishi, M ^a   Kusaba, I ^a   Masuda, H ^a   Tanaka, T ^a   Matsumata, T ^b   Sugimachi, K ^c  

^a KYUSHU DENTAL COLLEGE   (Japan)

^b Saiseikai Yahata General Hospital   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Invasiveness; Prognosis; Transforming growth factor receptor type II

Indexed keywords

GROWTH INHIBITOR; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; DISEASE COURSE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER;

EID: 0033926458     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0902     Document Type: Article

References (22)

1. Massague J. The transforming growth factor-β family. Ann Rev Cell Biol. 6:1990;597-614.
2. Sporn MB, Roberts AB. The transforming growth factor-β. Recent progress and new challenges. J Cell Biol. 119:1992;1017-1021.
3. Massague J, Attisano L, Wrana J. The TGF-β family and its composite receptors. Trends Cell Biol. 4:1994;172-178.
4. Lin H, Wang X-F, Ng-Eaton E, Weinberg R, Lodish H. Expression cloning of the TGF-β type II receptor a functional transmembrane serine/threonine kinase. Cell. 68:1992;775-785.
5. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang X, Massague J. TGF-β signals through a heteromeric protein kinase receptor complex. Cell. 71:1992;1003-1014.
6. Franzen P, ten Dijke P, Ichijo H, Yamashita J, Schulz P, Heldin C-H, Miyazono K. Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell. 75:1993;681-692.
7. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-β receptor. Nature. 370:1994;341-347.
8. Lopex-Casillas F, Wrana JL, Massague J. Betaglycan presents ligand to the TGF-β signaling receptor. Cell. 73:1993;1435-1444.
9. Sporn MB, Todaro GJ. Autocrine secretion and malignant transformation cells. N Engl J Med. 303:1980;878-880.
10. Sugiyama K, Yonemura Y, Miyazaki I. Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric cancer. Cancer. 63:1989;1557-1561.
11. Maekawa S, Saku M, Maehara H, Sadanaga N, Ikejiri K, Anai H, Kuwano H, Sugimachi K. Surgical treatment for advanced gastric cancer. Hepatogastroenterol. 43:1996;178-186.
12. Maekawa S, Saku M, Maehara H, Sadanaga N, Ikejiri K, Anai H, Kuwano H, Sugimachi K. Surgical treatment for advanced gastric cancer. Hepatogastroenterol. 43:1996;178-186.
13. Maehara Y, Oshiro T, Baba H, Ohno S, Kohnoe S, Sugimachi K. Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery. 117:1995;380-385.
14. Tateishi M, Toda T, Minamizono Y, Nagasaki S. Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma. J Surg Oncol. 49:1992;209-212.
15. Ichiyoshi Y, Taeishi M, Toda T, Minamizono Y, Nagasaki S, Yao T, Sugimachi E. Epidermal growth factor in gastric carcinoma as a risk factor of postoperative recurrence. Int Surg. 78:1993;196-199.
16. Kai T, Taketazu F, Kawakami M, Shimanuki K, Yamada S, Miyazono K, Kato M, Miyata M. Distribution of transforming growth factor-β and its receptors in gastric carcinoma tissue. Jpn J Cancer Res. 87:1996;296-304.
17. Chang J, Park K, Bang Y-J, Kim WS, Kim D, Kim S-J. Expression of transforming growth factor β type II receptor reduces tumorgenisity in human gastric cancer cells. Cancer Res. 57:1997;2856-2859.
18. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Ed. Gastric Cancer. 1:1998;10-24.
19. Maruyama M, Takeshita K, Endo M, Deakin M, Moossa AR. Clinicopathological study of gastric carcinoma in high- and low-mortality countries: Comparison between Japan and United States. Gastric Cancer. 1:1998;64-70.
20. Maehara Y, Okuyama T, Oshiro T, Baba H, Anai H, Akazawa K, Sugimachi K. Early carcinoma of the stomach. Surg Gynecol Obstet. 177:1993;593-597.
21. Kim IY, Ahn H-J, Lang S, Oefelein MG, Oyasu R, Kozlowski JM, Lee C. Loss of expression of transforming growth factor-β receptors is associated with poor prognosis in prostate cancer patients. Clin Cancer Res. 4:1998;1625-1630.
22. Takanami I, Tanaka F, Hashizume T, Kodaira S. Roles of the transforming growth factor β1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: results of an immunohistochemical study. J Surg Oncol. 64:1997;262-267.